The price hits a 2 year low of 24.5 cts. At 24.5 cts the forward p/e would be around 15.4 X on my estimated full year profits of S$8.2 mil. 9 months profit was S$6.1 mil.
The dividend yield is around 6.1% on price of 24.5 cts. I estimate full year dividend to be at 1.5 cts based on higher dividend declared at 1st half. This make it among the highest yield or highest yield stock in the health care sector.
I believe, going forward, the profits would be fairly stable as the population aged.
As i see it, the share price is unlikely to go much lower. The sell down was in low volume and probably from weak share holders.
I have increased my holding recently at around the 25 cts level and am looking forward to the full year results.
Express above are just my views n i stand corrected.
Last edit: 5 years 11 months ago by josephyeo. Reason: spelling
The portfolio has slipped into negative territory, registering a loss of 0.3%.
In the same period the ST Index is down 5.55% and Catalist Index is down 22.28%.
Of the 4 counters, 2 are profitable and 2 registered losses. The profitable counters are Singapore O& G and Chasen. The counters showing losses are Excelpoint and ISEC.
The full year results for Excelpoint, Singapore O& G and ISEC should be out around mid feb. I am expecting the results to be a catalyse for these 3 counters as all 3 are expected to report improved results cum very decent dividends. Chasen' s 3rd quarter should be out at about the same time.
If the results meet expectations, i am hopeful that the portfolio will show some profits.The annualised dividend yield for Singapore O& G and ISEC is above 5% at current price. Excelpoint, based on historical data, likely to declare a dividend of 4 cts or higher, giving a yield of around 7% or more.
Above is just an update for those who follow my post.
